FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

Aussie obesity pill claims to cut 18pc of your calorie intake Aug 1, 3:09 pm
Melbourne, Aug 1 (ANI): Australian researchers have revealed an obesity pill which could reduce a person's calorie intake by 18 percent.
Full Story
Exercising in teenage years cuts risk of early death in women Aug 1, 10:53 am
Washington DC, Aug 1 (ANI): A new research has suggested that women who exercise in their teenage years have a lower risk of death from cancer and other health isuues in their middle and older ages.
Full Story
Newly discovered cancer marker paves way for `deadly` breast cancer treatment Aug 1, 9:58 am
Washington DC, Aug 1 (ANI): Medical researchers have identified a new cancer maker, which could also be a possible therapeutic target for what is known to be one of the deadliest breast cancers.
Full Story
Black men likelier to die from prostate cancer than white counterparts Jul 31, 4:27 pm
London, July 31 (ANI): A new study has claimed that black men are twice as likely to suffer from prostate cancer as compared to white men.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY